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candidate mechanism is the microbiome–gut–brain axis 
possibly involving complex interactions between multiple 
systems, including the metabolic, immune, endocrine, and 
neural system. We conclude with practical implications and 
future directions into the investigation of an elimination 
diet’s efficacy in the treatment of attention deficit hyperac-
tivity disorder and autism spectrum disorder.
Keywords Elimination diet · Attention deficit/
hyperactivity disorder · Autism spectrum disorder · Food 
sensitivity · Gut–brain interaction
Introduction
Autism spectrum disorder (ASD) and attention deficit hyper-
activity disorder (ADHD) are early onset neurodevelopmen-
tal disorders that may persist into adulthood. Both ASD and 
ADHD are umbrella terms that cover heterogeneity of behav-
ioral abnormalities. ADHD is characterized by inattentive, 
hyperactive and impulsive behavior, whereas the key symp-
toms of ASD include social deficits, communication deficits 
and stereotypical behavior [1]. Despite the differences in the 
core behavioral symptoms between ASD and ADHD, there 
are indications for an overlap between the disorders. Indeed, 
research indicates that these disorders are highly comorbid 
[2–7]. This overlap could be explained by a shared etiology 
between ADHD and ASD disorders; for instance, genetic 
studies have demonstrated common genetic etiology for 
these disorders [8, 9]. Although the etiology of ASD and 
ADHD remains largely unknown, a complex interaction of 
genetic and environmental factors is thought to contribute to 
the development of ASD and ADHD [2, 10, 11].
One of the potential environmental risk factors for neu-
rodevelopmental disorders is diet [12]. Nutrition has an 
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impact on neurodevelopment, cognition, and behavior, 
and could therefore play an important role in neurodevel-
opmental disorders [13–15]. This insight, together with the 
lack of effective treatments for core ASD symptoms and 
the concerns about the safety of pharmacological treat-
ments in ADHD [16], have led to increasing research into 
the efficacy of nutrition-related interventions as additional 
or alternative (non-pharmacological) treatments for these 
disorders. The dietary interventions that have been sub-
jected to clinical trials include various forms of elimination 
diets and supplementation interventions [17–20]. In this 
review, we provide an overview of the literature with regard 
to the most common forms of elimination diets and their 
efficacy in ADHD and ASD. Furthermore, we discuss the 
potential mechanisms of elimination diets’ effects in both 
ADHD and ASD. Finally, we conclude with the practical 
implications and future directions into the investigation of 
elimination diets’ efficacy in the treatment of these early 
onset neurodevelopmental disorders.
Elimination diets in ASD and ADHD
At first, the concept of an elimination diet was introduced 
to diagnose and treat food allergies [21]. The main reason 
for applying an elimination diet is to find out which foods 
are causing or aggravating physical adverse reactions. Later 
this link of food with adverse physical adverse reactions 
has been extended to a connection with neurobehavioral 
symptoms [22, 23]. Thus, in this later view, behavioral 
reactions are seen as possible adverse reactions to food as 
well. In the domain of psychiatry, it is therefore believed 
that elimination diets can be used to identify foods that 
contribute to mental disorders and associated behavioral 
and cognitive disturbances.
Elimination diets come in different forms and vary 
in their strictness and food items that are being elimi-
nated. Interestingly, the forms of elimination diets that are 
being investigated differ between ASD versus ADHD. In 
ASD, the gluten-free and/or casein-free (GFCF) diet has 
been mainly investigated, whereas in ADHD, clinical tri-
als examined the effects of food additives exclusion diets 
and the oligoantigentic diets. These differences in focus 
between the elimination diets that are applied in the two 
disorders are due to the different origins of the research in 
both fields. In the following sections, the origins, rationale, 
and the general principles of the diets are being described, 
followed by the degree of evidence with regard to the effi-
cacy. In Table 1, an overview is provided for several charac-
teristics of the respective diets, including the excluded food 
items, main target group, efficacy, and nutritional elements 
that would require attention in case of long-term exclusion 
to avoid deficiencies.
Gluten‑free diet and/or casein‑free diet in ASD
The focus on GFCF diets in ASD originates from the 
evidence of comorbid gastrointestinal tract problems in 
patients with ASD [24–26]. The explanation for increased 
gastrointestinal problems in ASD remains unclear. One 
explanation is that gastrointestinal tract problems in 
patients with ASD might be caused by increased intesti-
nal permeability, the so-called leaky gut, which has indeed 
been demonstrated in children with ASD compared to 
healthy controls [27–29]. According to the ‘opioid excess 
theory’, digestion of gluten and casein produces peptides 
with an opioid activity that can enter the bloodstream when 
the gut permeability is high [30, 31]. These neuroactive 
peptides can in turn bind to opioid receptors and are there-
fore speculated to affect processes in the central nervous 
system [32].
The idea for the gluten-free diet involves examination of 
the effects of removing all the food items containing gluten, 
a mixture of proteins found in wheat, oats, barley, or rye. 
Thus, all products made with these cereals are excluded 
from the diet and replaced with special gluten-free version 
of the common food items. In some cases, the gluten-free 
diet is combined with a casein-free diet. Casein is a peptide 
commonly found in milk. Thus, a casein-free diet involves 
avoiding the intake of milk and dairy products. After a 
period of elimination, products containing gluten or casein 
can be reintroduced to test whether it is contributing to the 
symptoms.
Food additives exclusion diet in ADHD
As discussed above, the elimination diet was originally 
proposed as a tool for treatment of food allergies [21]. 
Feingold, an American pediatrician and allergist, was the 
first who suggested that allergy to food additives, such as 
artificial flavors and colors, as well as naturally occurring 
salicylates could lead to ADHD symptoms [33]. He based 
this on observations that aspirin, which contains salicy-
lates, could not only lead to allergic reactions, but also to 
an increase of hyperkinetic behavior in some patients. This 
observation has set the stage for the development of vari-
ous food additives exclusion diets, which typically involves 
the removal of, for instance, artificial food colors, flavors, 
fragrances, preservatives, and sweeteners. Sometimes, 
this diet is part of a broader elimination diet, such as the 
Feingold diet or Kaiser Permanente diet (http://feingold.
org/), which involves the removal of both natural and arti-
ficial salicylates. The intervention usually investigates the 
effect over periods of a week or longer. Food challenges 
that include food additives can be used after this period to 
examine the acute immediate effects of the challenge. The 
hypothesis is that ADHD could be influenced by either 
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allergenic or pharmacologic mechanisms related to levels 
of salicylates and salicylates-like substances.
Oligoantigenic diet in ADHD
In oligoantigenic diets, the focus is on eliminating sus-
pected high allergenic food products rather than eliminating 
artificial colors, flavors, and preservatives specifically. An 
oligoantigenic diet intervention, also known as a restricted 
elimination diet or hypoallergenic diet, involves the test-
in657g of an individually constructed restricted elimination 
diet. The focus is on eliminating foods that are often found 
to be highly allergenic, such as cow’s milk, cheese, egg, 
chocolate, and nuts. Oligoantigenic diets come in different 
forms and vary in their strictness. The oligoantigenic diet 
typically involves an elimination phase (usually two to five 
weeks) in which the specific food items are excluded com-
pletely. The food items in the elimination phase could, for 
instance, consist of only a few hypoallergenic foods such 
as rice, turkey, lettuce, pears, and water [34]. If the patient 
reacts by a substantial decrease of symptoms indicating 
‘food sensitivity’, a reintroduction phase, which could take 
as long as eighteen months, could be applied to find out 
what specific food items trigger the symptoms. Thus, an 
elimination diet can be regarded as a ‘diagnostic’ tool for 
determining whether specific foods cause adverse physical 
and/or behavioral reactions.
Evidence for elimination diets’ effects on ADHD 
and ASD symptoms
Gluten‑free/casein‑free diet in children with ASD
There is increasing research into the effectiveness of 
the GFCF diet in children diagnosed with ASD. Several 
systematic reviews of GFCF diet studies in ASD have 
appeared [19, 35–40]. However, the number of high qual-
ity RCTs is too small for drawing firm conclusions at this 
point and there are no meta-analyses available. Overall, 
the findings with regard to GFCF diet’s effect in ASD are 
mixed. Several studies suggest no effect of the GFCF diet’s 
effect in ASD [41–43]. For instance, a recent study testing 
the effects of a GFCF diet in children with ASD (n = 30) 
involving a double-blind placebo-controlled challenge 
phase did not demonstrate positive effects on measures 
of physiological functioning, behavior problems, or ASD 
symptoms [41]. However, children with known gastrointes-
tinal disorder were excluded, which could have weakened 
any potential effects [41]. In fact, there is research suggest-
ing that gastrointestinal issues might go together with ASD 
behavioral symptoms and reactions to gluten and casein 
[46, 47]. Two RCTs investigated GFCF diet’s effect in ASD 
by following children with ASD (n = 10 and n = 72) for 
1 year [44, 45]. The data demonstrated positive effects of 
the GFCF diet on ASD trait measures. However, the out-
come measure was based on unblinded caregivers’ reports 
and the studies did not control for concomitant treatments 
that the children may have received while being enrolled 
in the studies. Furthermore, the attrition rate was nearly 
a quarter in one of the studies, which was not taken into 
account in the analysis.
Elimination diets in children with ADHD
The effectiveness of the food additives exclusion diet as 
treatment for ADHD has been investigated in a number of 
studies [17, 18, 48]. Only some studies additionally elimi-
nated food items containing natural salicylates as part of 
a broader diet, such as the Feingold diet or Kaiser Perma-
nente diet [49, 50]. A meta-analysis with a focus on the 
effectiveness of such elimination diets in ADHD across 
twenty studies including 794 participants found a small 
effect size based on parent reports, 0.18, that decreased to 
0.12 when taking into account possible publication bias 
[51]. The effects based on teachers’ reports and observer 
measures were not significant. However, pooling the data 
of a limited number of high quality studies for analyses in 
this meta-analysis demonstrated small effects on teacher 
ratings and neurocognitive attentional tests. In another 
meta-analysis, focusing exclusively on ADHD outcomes 
and more critically addressed assessment blinding issues, 
eight studies including 294 participants reported an effect 
size of 0.32 for the most proximal assessment and 0.42 
for the probably blinded assessments [18]. It is important 
to note though that the effects of this meta-analysis may 
be limited to children with ADHD who have sensitivity to 
food colors, as the participants were often preselected on 
the basis of a suspected sensitivity to food colors during the 
elimination phase of the diet. Furthermore, rather than an 
increase in the effect size, additional analysis using only 
trials with low/no comedication to exclude the impact of 
effective medication led to a reduction in the effect size to 
a non-significant level [18]. Stevenson et al. reported that 
high quality studies showed an effect size of 0.21 and 0.22 
of food color elimination; however these studies were not 
restricted to children diagnosed with ADHD [17]. It has 
been suggested that the effect of food color elimination on 
behavior is probably not limited to children with a diagno-
sis of ADHD, but rather also applies to hyperactive behav-
ior in children more generally [48].
With regard to oligoantigenic diets, the effectiveness 
of the elimination phase has been demonstrated in sev-
eral randomized clinical trials with patients with ADHD. 
An effect size of 0.29 has been reported in a meta-analy-
sis across six controlled trials including 195 participants; 
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it was concluded that about one third of the children with 
ADHD show an excellent (>40% symptom reduction) 
response [51]. This meta-analysis excluded two studies by 
Pelsser et al. with an outlier effect size and the use of non-
blinded ratings [34, 52]. Another meta-analysis including 
these two studies estimated an effect size of 1.48 that, how-
ever, dropped substantially to 0.51 (95% confidence inter-
val −0.02 to 1.04) when probably blinded raters were used 
[18].
Taken together, it remains inconclusive whether elimina-
tion diets are effective as a treatment for children with ASD 
and ADHD. So far, the evidence for GFCF diets as an effec-
tive treatment for children with ASD is weak, but it might 
be a beneficial intervention for a subset of children with 
ASD, particularly for those with comorbid gastrointestinal 
problems. The observed effects for food additives exclu-
sion diets in children with ADHD are small, and may not 
be specific for children with ADHD. Although a few select 
studies using most proximal assessment demonstrated large 
effects of oligoantigenic diets in children with ADHD [34, 
52], an overall small effect of this diet was shown by other 
studies using probably blinded assessments. Furthermore, 
it remains unknown whether children will have a consoli-
dated diet after the elimination phase of the oligoantigenic 
diet. This question calls for studies that include food chal-
lenges or a reintroduction phase in the study design. Dou-
ble-blind placebo-controlled challenges or reintroduction 
phases after positive reactions to eliminations are useful for 
further investigations to test the effects of the food items 
in a systematic and controlled way. Studies that assess the 
long-term effectiveness are necessary to draw conclusions 
about elimination diet’s effects in children with ADHD 
and ASD. Finally, contrary to most aforementioned work, 
future studies should adopt the gold standard for clinical 
trials, i.e., high quality randomized controlled trials with 
blinded raters for the primary outcome.
Mechanisms of elimination diets’ effect
Food allergy and hypersensitivity
A typical food allergic reaction is mediated by spe-
cific immunoglobulin (Ig) antibodies, IgE. Such IgE-
mediated allergic reaction has an immediate onset of 
symptoms within several minutes to several hours after 
contact with the allergen. The dietary interventions in 
children with ASD have mainly focused on the elimi-
nation of gluten and/or casein and were based on the 
hypothesis that children with ASD have an increased risk 
of immune responses to these substances. Although no 
association between gluten sensitivity and ASD has been 
reported based on immune markers [24], serum levels of 
immunoglobulin antibodies IgA, IgG, and IgM specific 
for milk-derived allergens and total IgE were increased in 
children with ASD compared with controls [53]. In addi-
tion, stimulation of peripheral blood mononuclear cells of 
children with ASD using milk-derived allergens produced 
more pro-inflammatory cytokines compared to controls 
[54]. Overall, there is increasing evidence that dysregu-
lation of the immune system plays an important role in 
ASD. For instance, it has been shown that children with 
ASD have reduced regulatory T cell response, indicating 
reduced tolerance to antigens in these children [55]. ASD 
has also been associated with increased levels of pro-
inflammatory cytokines in the blood, and decreased lev-
els of anti-inflammatory cytokines [56, 57]. Furthermore, 
deficiencies in the complement system, which plays 
an important role in promoting immune cells to clear 
microbes, infected cells, and cellular debris, have also 
been demonstrated in ASD [58, 59]. Taken together, there 
is some indication that ASD is linked to food allergy or 
‘hypersensitivity’, which could provide an explanation 
for the potential efficacy of GFCS diets in the treatment 
of ASD.
The aim of food additives exclusion diet and oligoan-
tigenic diet is to eliminate foods from the diet that trigger 
adverse physical, allergic reactions. Thus, the concept of 
these diets is based on a link between ADHD and allergic 
reactions to food. It has been shown that children with 
ADHD have an increased risk of developing allergies 
and vice versa [60, 61]. However, so far there is no con-
vincing evidence for food allergy or hypersensitivity to 
be involved in ADHD. For instance, no differences were 
found between patients with ADHD and healthy controls 
on a skin prick test to food allergens [62]. Moreover, 
hyperactive children who responded to a challenge test 
with allergenic food products did not demonstrate posi-
tive skin prick tests [63]. These findings may suggest that 
ADHD is associated with a non-IgE-mediated reaction to 
food. It has been hypothesized that determination of IgG 
may be helpful in these cases, such that foods that induce 
high IgG-levels would lead to a worsening of symptoms, 
while foods that induce low IgG-levels would not. How-
ever, there is no evidence for IgG as a potential marker 
at this point. In a previous study, a challenge test with 
allergenic foods has led to relapse of ADHD symptoms 
independently of influences on IgG blood levels, thus 
questioning the role of IgG-mediated mechanisms [34]. 
Despite the lack of clear serological markers indicat-
ing food allergy in ADHD, future studies should further 
investigate this open question and examine whether food 
allergy or hypersensitivity could play a role in ADHD 
and mediate elimination diets’ effects, particularly given 
the previous findings suggesting a link between ADHD 
and allergies [60, 61, 64].
1072 Eur Child Adolesc Psychiatry (2017) 26:1067–1079
1 3
Microbiome–gut–brain axis
Diet and the role of the microbiome in health and disease
The intestinal microbial flora is involved in appetite regula-
tion, energy utilization, digestion and absorption of nutri-
ents [65, 66]. Additionally, our microbiome plays a crucial 
role in health and disease by influencing immune function, 
drug metabolism and protection against pathogens [67–69]. 
Disruption of the microbiome composition or dysbiosis has 
been associated with several human diseases, including 
inflammatory bowel diseases, cancer, obesity, metabolic 
syndrome and neurological disorders [70–77]. Moreo-
ver, the role of microbiome in multiple complex disorders 
is supported by evidence from safe treatment using fecal 
transplants in inflammatory bowel diseases, but also in dis-
orders less directly linked to the gut, like multiple sclerosis 
and chronic fatigue syndrome [78]. Current evidence from 
animal studies convincingly shows that the composition 
of the microbiome has an impact that is even beyond dis-
ease, (co-)determining mood, stress response, and several 
aspects of behavior [79–82]. Diet is an important determi-
nant of gut microbiota composition and functioning that is 
strongly linked with psychopathological outcomes [83–85]. 
Together, these findings suggest that there is a link between 
diet, the composition of the gut microbiome and mental 
disorders.
Multiple pathways in the microbiome–gut–brain axis
The effects of the microbiome on brain function, behavior 
and diseases can be mediated through different pathways of 
the so-called microbiome–gut–brain axis, involving neural, 
as well as metabolic, immune and endocrine mechanisms 
[79, 86–88]. A number of reviews have provided a thor-
ough overview of these complex interactions [79, 86–88]. 
In brief, at least three pathways have been suggested to link 
the gut microbiome with brain function. First, the brain and 
the intestinal system are connected via the vagus nerve, a 
major nerve of the parasympathetic nervous system. The 
microbiome could influence brain function by innervation 
of the vagus nerve. The vagus nerve seems to differenti-
ate between non-pathogenic and pathogenic bacteria and 
mediate signals that can induce anxiogenic and anxiolytic 
effects depending on the nature of the stimulus. These 
effects potentially involve immunomodulatory mechanisms 
[89]. For example, in a rodent study, it has been shown 
that ingestion of the Lactobacillus rhamnosus reduced 
stress-induced corticosterone and anxiety- and depression-
related behavior [90]. These effects were accompanied by 
alterations in central γ-aminobutyric acid (GABA) recep-
tor expression, which has often been associated with anxi-
ety, depression, and bowel disorders [91]. Crucially, these 
neurochemical and behavioral effects were not found in 
vagotomized mice, suggesting that the vagus nerve plays a 
mediating role in these effects and functions as a commu-
nication pathway between gut bacteria and the brain [90]. 
Second, the microbiome could influence brain function 
via interactions with the immune system [92, 93]. Bacte-
rial species can affect the immune system effects through 
the production of immune-regulatory metabolites, such 
as short-chain fatty acids (SCFAs) [94–96]. Alterations in 
regulation of neuroactive bacterial products or metabolites, 
can alter gene expression, influence the immune system, 
and interact with nerve cells by stimulating the sympathetic 
nervous system [97–99]. Third, the composition of the 
microbiome might influence the levels of neurotransmitters 
and thereby processes in the brain. For instance, bacterial 
strains can influence the synthesis and thereby the release 
of serotonin, a key neurotransmitter in the gut–brain con-
nection that plays an important role in gastrointestinal and 
neurobehavioral regulations [100–102]. A recent rodent 
study has shown evidence that indigenous spore forming 
bacteria are able to stimulate serotonin-producing colonic 
enterochromaffin cells and modulate gastrointestinal motil-
ity via metabolic signaling with specific metabolites. Fur-
thermore, an increase of the particular metabolites was 
associated with increases in colonic and serum serotonin in 
the mice, suggesting an important role of the spore forming 
bacteria in the regulation of serotonin levels and serotonin-
related processes in the host. In addition to serotonin and 
SCFAs, gut bacteria are also capable of producing an array 
of other neuroactive and immunomodulatory compounds, 
including dopamine, GABA, histamine, and acetylcholine 
[103–106].
The role of the microbiome–gut–brain axis 
in neurodevelopment
The development of the microbiome–gut–brain axis hap-
pens early in life. The bacterial colonization is a postna-
tal event, which commences at birth. After one-to-three 
years of age, a complex adult-like microbiome is evident 
and stable [107–109]. Parallels can be drawn between the 
development of the microbiome and the development of 
the central nervous system suggesting that critical windows 
in neurodevelopment might be linked to critical periods in 
the colonization of the microbiome [86]. It has therefore 
been suggested that the microbiome–gut–brain axis plays 
an important role in neurodevelopmental disorders [86, 
88]. However, the precise factors in the microbial com-
position that may cause disruptions in neurodevelopmen-
tal processes are not yet identified. Nevertheless, there is 
some evidence in support for this idea: for instance, it has 
been shown that germ-free mice have an exaggerated HPA-
axis response to an external stressor, while this effect was 
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reversed by administration of the feces from specific path-
ogen-free mice with normal gut microbiota at early stage 
of development, but not at later stage [110]. This suggests 
that exposure to endogenous microbiota at an early devel-
opmental stage is required for the HPA system to become 
fully susceptible to inhibitory neural regulation. More gen-
erally, these findings suggest that the microbiome may con-
tribute to critical windows in neurodevelopment, and it is 
relevant to consider the role of the microbiome in neurode-
velopmental disorders, such as ASD and ADHD.
The role of the microbiome–gut–brain axis in ASD
In individuals with ASD, altered composition of the intes-
tinal microbiota has been demonstrated [111–115]. For 
instance, studies in ASD have found Clostridium or Des-
ulfovibrio bacteria clusters over-represented in children 
with gastrointestinal complaints and ASD as compared to 
children with similar gastrointestinal complaints but typical 
neurobehavioral development [113, 116, 117]. Although 
the results with regard to the specific species of microbes 
that are altered in individuals with ASD versus controls are 
inconsistent across studies, alterations in the Clostridium 
species have been reported across several studies in indi-
viduals with ASD [111, 113, 117]. Clinical improvement 
has additionally been reported anecdotally in children 
with ASD who develop fever [118], receive oral antibiot-
ics [119], or ingest probiotics [120], all of which likely 
alter the gut microbiome. Using an animal model of ASD 
with gastrointestinal and neurological symptoms, the sup-
ply of Bacteroides fragilis, commensal intestinal bacteria, 
has been shown to reduce the gastrointestinal symptoms, 
improve the intestinal barrier permeability, and reduce 
ASD-related behavioral disturbances [121].
As discussed previously, other theories with regard to 
the mechanism underlying elimination diet’s effects in 
ASD relate to metabolic deficiencies (though not exclud-
ing a role of the microbiome). It has been postulated 
that ASD is the result of a metabolic disorder in which opi-
oid peptides produced through metabolism of glu-
ten and casein pass through an abnormally high permea-
ble intestinal membrane (‘opioid excess theory’ or ‘leaky 
gut theory’) [27–31]. These neuroactive peptides can then 
enter the blood stream and exert an effect on neurotrans-
mission through binding with opioid receptors. Indeed, a 
higher permeability of the gut has been found in children 
with ASD compared to the gut permeability of healthy 
controls [27]. However, so far experiments have failed to 
detect any abnormal high levels of opioid peptides in chil-
dren with ASD [122]. Another potential theory relates 
to oxidative stress and sulfur metabolic deficiencies. In a 
vicious circle, sulfur metabolic deficiencies might influence 
the bacterial composition and bacterial products leading to 
elevated oxidative stress in individuals. Together, bacterial 
products, oxidative stress and dietary allergens could lead 
to increased intestinal permeability [123]. Neuroinflamma-
tion, affecting the protective blood–brain-barrier capacity, 
as a result of increased gastrointestinal permeability could 
contribute to ASD. Therefore, a dietary treatment that is 
able to restore the gut permeability can be effective as a 
treatment for children with ASD [123–125].
The role of the microbiome–gut–brain axis in ADHD
Although direct evidence for a role of changed microbi-
ome–gut–brain interaction is currently lacking in ADHD, 
converging evidence suggests that similar alterations 
in microbiome–gut–brain interaction can contribute to 
ADHD symptoms as well [64, 126]. Our group has recent 
unpublished data showing that gut microbiome is altered 
in ADHD. More specifically, increases in the genus Bifi-
dobacterium in ADHD versus controls contributed to the 
increased metabolic function of cyclohexadienyl dehy-
dratase, an enzyme that is involved in the synthesis of the 
essential amino acid and dopamine precursor, phenylala-
nine. Furthermore, in the same study, we demonstrated that 
these metabolic changes were related to decreased ventral 
striatal signals to reward anticipation, a neural hallmark of 
ADHD [127, 128]. These findings could be an important 
first step towards a better understanding of the relationship 
between alterations in the microbiome–gut–brain axis and 
ADHD symptoms. Further investigations are necessary to 
establish this relationship, and the role of diet.
Family relationships and structure
Since strict parental supervision is necessary for the appli-
cation of an elimination diet, one could argue that elimi-
nation diets’ effects might be explained by concomitant 
adaptations in parental behavioral strategies and care. It is 
known that parents of children with ADHD and ASD use 
different parenting structure and have a different relation-
ship with their children [129–131]. Furthermore, consistent 
parenting and positive parent–child interactions are associ-
ated with improvements of child behavior [132]. Although 
it should be noted that for ADHD, behavioral interventions 
mainly have shown positive effects on other outcomes that 
are associated with the disorder rather than on the pri-
mary symptoms of the disorder [18, 133]. Nevertheless, 
one could argue that there is a possibility that elimina-
tion diets’ effects as reflected by behavioral improvements 
might be mediated by the change in parenting structure 
required for the application of the elimination diet, rather 
than by a direct result of dietary changes per se. However, 
this hypothesis has not been supported by any evidence so 
far. In a previous study, it was demonstrated that families 
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of children with ADHD, who were motivated to follow an 
elimination diet, already showed a good family environ-
ment, i.e., no difference compared to families of health 
controls. Moreover, the elimination diet did not affect the 
family relationships and structure [134]. More research is 
necessary to investigate whether family relationships, fam-
ily structure, and other psychosocial variables may play a 
potential role in elimination diet’s effects.
In sum, the mechanism underlying the effectiveness 
of the elimination diet is yet unknown. The microbiome–
gut–brain axis is the main candidate mechanism and could 
potentially involve interactions between allergic reactions, 
intestinal permeability, oxidative stress, and alterations in 
microbiome composition and function. Characterization of 
the direct and indirect pathways of the microbiome–gut–
brain connection is important, as it can ultimately inform 
clinicians as to potential markers and targets for (preventa-
tive) treatment. Furthermore, this knowledge acquisition is 
an important step in the development of novel nutritional/
therapeutic interventions tailored at the individual patient. 
More knowledge about the mechanisms underlying elimi-
nation diets’ effects in ADHD and ASD is needed.
Clinical implications and future research
The GFCF diet might be beneficial for children with ASD 
and food intolerance/allergy or underlying gastrointesti-
nal disease. However, the evidence for the effectiveness of 
GFCF diets in children with ASD is weak and thus these 
diets cannot be generally recommended as a treatment for 
children with ASD. Yet, a GFCF diet is a commonly applied 
intervention in children with ASD in practice. Many par-
ents may feel it is better to apply any available treatment 
when searching for treatment for their child with ASD as 
therapies for treating core symptoms of ASD are limited. 
However, using a GFCF diet may not be without harm (e.g., 
stigmatization, diversion of treatment resources, nutritional 
deficiency) [135]. Hence, until there is conclusive evidence 
for the benefits of GFCF diets for children with ASD, it is 
the task of health professionals and researchers to commu-
nicate with caregivers and inform them about the costs and 
potential adverse consequences.
Benefits of food additives exclusion diets have been 
suggested in children diagnosed with ADHD. However, 
the observed effects are small, which makes food addi-
tives exclusion diet not qualified as stand-alone treatment. 
Nevertheless, given the positive, albeit small effects of this 
intervention in children with ADHD as well as in children 
from the general population, and the fact that food addi-
tives do not provide any health benefits, it is recommended 
that children preventatively minimize consumption of pro-
cessed food products with these ingredients. Moreover, 
from a public health perspective, food industry might 
change its policy and lower or even avoid adding unneces-
sary additives to food.
With regard to oligoantigenic diets, if applied under close 
supervision, these interventions could be valuable instruments 
to assess whether ADHD is triggered by food. However, the 
efficacy of this diet as a treatment for ADHD remains to be 
investigated as there are no studies yet that have demonstrated 
long-term beneficial effects of this treatment after consoli-
dating the diet. Our research group is currently conducting a 
large clinical trial to assess the long-term beneficial effects of 
an oligoantigenic diet in children with ADHD.
Previous work has shown that only a subset of the chil-
dren with ADHD responds to an oligoantigenic diet [34]. 
However, the characteristics of responders versus non-
responders remain to be determined in future work. In the 
application of an elimination diet, it is important to take the 
individual differences in treatment response into account. 
First observations from our ongoing randomized controlled 
trial (www.project-trace.nl) suggest that some children 
might not improve on the primary symptoms, but rather 
on symptoms that usually accompany the disorder, such as 
emotion regulation problems (e.g., irritability) and physical 
symptoms (e.g., intestinal disturbances). These observations 
might suggest that the effects of an elimination diet are not 
per se symptom/diagnosis specific and it could be impor-
tant to monitor changes in different domains that are rele-
vant for the well-being of the child. Furthermore, we have 
observed large individual differences in terms of time that 
is needed for any positive effects of the diet to surface dur-
ing the elimination phase. Some children appear to be ‘fast-
responders’, who show a positive reaction after a few days, 
whereas other children are ‘slow-responders’, who show a 
positive reaction after a couple of weeks. It remains to be 
investigated what could explain these individual differences 
and whether these individual differences are useful indica-
tors for optimizing the individual treatment by reducing the 
duration of the treatment. Similarly, individual variation 
during the reintroduction phase is evident, with aggrava-
tion of ADHD symptoms in some children after food rein-
troduction after 5 days, whereas others only respond after 
10–14 days. In addition, children with little variation in 
their normal food habits tend to respond more strongly to 
the intervention, but also seem to have the most difficulty 
in adhering to the diet since they dislike many foods that 
are present in the elimination phase. This may result in 
the child eating too few different foods during this phase, 
increasing the risk for non-adherence since the elimination 
phase is then overly strict. For the feasibility of this inten-
sive treatment, it is also crucial to consider the optimal 
moment to start the diet. Stressors or life events, such as 
change of school environment or family structure, illnesses, 
but also positive events, such as celebrations and holidays, 
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may negatively impact the motivation and feasibility of the 
successful application of the treatment. The reintroduction 
phase is the most intensive part of the treatment given its 
long duration. Close supervision by professionals when 
applying this diet or any other elimination diet is necessary 
such that effects of the diet as well as parent–child relation-
ships can be monitored, the diet can be adjusted if needed, 
and training, support and guidance can be given to prevent 
the risk of adverse consequences. Apart from stigmatization, 
diversion of treatment resources, and nutritional deficiency, 
parent–child interaction problems may also be a risk. For 
instance, it has occurred that the child seized the opportunity 
to put pressure on parents to get what he/she desires with 
the ‘threat’ of not adhering to the diet. Practitioners should 
inform the caregivers that an elimination diet requires a 
change of lifestyle, and success will depend largely on the 
level of control over the child’s diet and behavior, and the 
resources and organizational capacities within the family. 
Finally, caregivers should be reminded that the decision to 
explore the effects of an elimination diet should be weighed 
against potential adverse consequences.
Future research is necessary to establish the clinical util-
ity of elimination diets in the treatment of children with 
ADHD and ASD, particularly considering the widespread 
use of these treatments. Adequately powered, long-term 
RCTs, including blinded assessment of the primary out-
come, should be conducted to determine the effectiveness 
and cost-effectiveness of elimination diets for children 
with ADHD and ASD. In these trials, a reintroduction or 
food challenge phase, preferably double-blind placebo-
controlled, should take place after the elimination phase 
to determine the effects of the eliminated food items thor-
oughly. It remains to be investigated whether effects of spe-
cific foods can be specific for certain disorders or behavio-
ral problems. In addition, many questions pertaining to the 
feasibility of these treatments remain to be answered. Attri-
tion rates ranging from 0 to 25% have been reported in the 
literature, but these numbers were mostly based on a range 
of short-term trials with large heterogeneity in the designs 
(e.g., in preselection of patients, duration of trial, and 
nature of controlled challenge phase of the experiment). 
Thus, long-term clinical trials are particularly important for 
answering questions related to feasibility. Finally, this work 
should investigate how biopsychosocial variables may be 
affected by the treatment and may play a role in the effi-
cacy of the treatment.
New avenues should also include the identification of 
predictors of treatment response, especially given that elim-
ination diets may only improve the behavior in a (small) 
subset of the affected children. Future research might also 
target the microbiome–gut–brain connection as a potential 
mechanism that underlies the development of neurodevel-
opment disorders and elimination diets’ effect in reducing 
symptoms [126, 136]. A multidisciplinary approach is 
essential for the investigation of the relation between the 
microbiome–gut–brain connection and behavioral symp-
toms of ASD and ADHD, which potentially involves mul-
tiple systems, including the metabolic, immune, endocrine, 
and neural system. The knowledge acquisition pertaining to 
the mechanism of action could ultimately help inform clini-
cians about potential markers and targets for preventative 
and individualized treatment.
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